Full-Time

Head of Cancer Care

Posted on 10/31/2024

Transcarent

Transcarent

501-1,000 employees

On-demand medical access and delivery

Compensation Overview

$210k - $230k/yr

+ Bonus + Stock Options

Remote in USA

Remote

Candidates must be authorized to work in the United States. There may be a preference for specific locations, but the job is generally open to remote work anywhere in the US.

Category
Medical, Clinical & Veterinary (1)
Required Skills
Market Research
Requirements
  • Bachelor’s Degree; master's degree or higher in a health care or business-related field, preferred
  • 12+ years related experience
  • 5+ years people leadership experience
  • Healthcare provider contracting experience beyond fee for service; specifically with value based, bundled payment models and services
  • Expertise in cancer care required, including an understanding of the complexities of Cancer and Cancer care and the challenges a Member faces as they progress through their care journey.
  • Experience with strategy development in healthcare solutions and demonstrated experience launching new solutions in the market
  • Experience with payers and knowledge of their key success drivers
  • Deep knowledge of competitive landscape and innovation drivers
  • Ability to direct market research to understand stakeholder needs to guide decision-making & strategy formulation
  • Technology fluency in articulating technical needs to enable the solution
  • Excellent communication and presentation skills
Responsibilities
  • Understanding and responding to client, Member and partner needs; competitor solutions and direction; and articulating and developing a differentiated suite of Cancer solutions.
  • Designing, implementing, and overseeing the cancer solution and future enhancements.
  • Provide leadership, coaching, and development to a team of direct reports while leading and guiding cross-functional partners to collectively achieve program goals.
  • Manage the P&L of the cancer solution, ensuring high growth, financial health and profitability.
  • Directly influence and drive the strategic direction of the cancer solution roadmap, aligning it with business objectives and market demands.
  • Drive pricing strategies and initiatives to enhance market traction, ensuring competitive pricing while maximizing revenue.
  • Drive the work in providing GTM teams with marketing collateral, client facing demos, and client conversations.
  • Lead the decision-making process regarding partnerships, contracting and compliance matters.
  • Foster growth, collaboration, and innovation with our current partners while driving and developing new relationships with potential partners.
  • Align all cancer solution stakeholders and works cross functionally to deliver industry leading performance.
  • Responsible for all core KPIs including Market Adoption (in collaboration with Sales and Client Success), Member Adoption (in collaboration with Product and Member Engagement)
  • Other responsibilities as required.
Desired Qualifications
  • master's degree or higher in a health care or business-related field, preferred
  • Experience in innovative cancer solutions providing digital and other health services to cancer patients preferred

Transcarent runs a digital health platform for individuals, families, and employers, offering 24/7 access to doctors via chat, personalized care guidance from health concierges, and doorstep medication delivery. Members join through employer plans or directly, then use the app or website to chat with doctors within 60 seconds, receive tailored care help, and order medicines to be shipped to their home. It differentiates itself by pairing immediate medical access with concierge support and cost transparency, supported by subscription options for employers and premium plans for individuals. The goal is to make healthcare less confusing, simpler to navigate, and more affordable by delivering easy access to care, trusted guidance, and clear information.

Company Size

501-1,000

Company Stage

Series D

Total Funding

$424M

Headquarters

San Francisco, California

Founded

2020

Simplify Jobs

Simplify's Take

What believers are saying

  • Transcarent raised $126M Series D and prior $200M Series C, fueling growth.
  • $621M Accolade acquisition serves 1,400+ employer clients with GenAI specialty care.
  • FDA eases AI device regulations in 2026, boosting Transcarent's virtual care tech.

What critics are saying

  • 98point6 integration fails, disrupting services and eroding trust within 6-12 months.
  • Amazon Clinic free virtual care captures market share from Transcarent subscriptions in 3-6 months.
  • Bluespine AI falsely flags claims, sparking lawsuits and client churn in 6-12 months.

What makes Transcarent unique

  • Transcarent integrates AI-powered payment integrity via Bluespine partnership to combat $300B healthcare fraud.
  • Transcarent acquires 98point6 for AI virtual care and Accolade for $621M health advocacy expansion.
  • Transcarent delivers 24/7 doctor chats in 60 seconds plus medication delivery for self-insured employers.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Transcarent who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Unlimited Paid Time Off

Paid Vacation

Mental Health Support

Wellness Program

Growth & Insights and Company News

Headcount

6 month growth

-2%

1 year growth

-4%

2 year growth

-6%
Business Wire
Mar 17th, 2026
Transcarent partners with Bluespine to tackle $300B healthcare fraud with AI-powered payment integrity

Transcarent has launched a payment integrity category in its Experience Store through a partnership with Bluespine, an AI-driven health technology company. The initiative aims to help self-insured employers detect overbilling and reduce waste in healthcare spending. Fraud, waste and abuse account for an estimated 3% to 10% of total US healthcare spending, representing over $300 billion annually. Unlike traditional audits that review limited claim samples, Bluespine analyses 100% of medical and pharmacy claims using AI to identify overpayments, policy violations and billing errors. The platform supports both prepayment review and post-payment recovery, validating claims against employers' specific plan documents, coverage exclusions and negotiated rates. Every identified issue is documented with clear evidence tied to plan language or billing guidelines, enabling streamlined recovery without disrupting member experience.

Business Wire
Jan 9th, 2025
Transcarent To Acquire Accolade

Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and primary care, an

FinSMEs
May 2nd, 2024
Transcarent Raises $126M in Series D Funding

Transcarent, a San Francisco, CA-based healthcare platform provider, raised $126m in Series D funding

Business Wire
Mar 8th, 2023
Transcarent to Acquire 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent, a health and care experience company that makes it easy for people to access high-quality, affordable care announced plans to acquire the

FinSMEs
Jan 11th, 2022
Transcarent Raises $200M in Series C Funding

Transcarent, a Palo Alto, Calif.-based health and care experience company, raised $200m in Series C funding

INACTIVE